Editorial

» epigenetics, cancer and opinion

Most Recent

image: Agents Provocateurs

Agents Provocateurs

By | April 1, 2012

Asking pointed questions is a key part of the scientific process.

3 Comments

A Truly Happy Return

By | December 1, 2011

After a roller-coaster of an October, The Scientist resumes publication under new ownership.

12 Comments

image: Seeing the Forest for the Trees

Seeing the Forest for the Trees

By | August 1, 2011

Getting the big picture means asking lots of little questions.

0 Comments

image: A Shot in the Arm

A Shot in the Arm

By | June 1, 2011

Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.

0 Comments

image: The “Me Decade” of Cancer

The “Me Decade” of Cancer

By | April 1, 2011

Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.

0 Comments

image: Epigenetics and Society

Epigenetics and Society

By | March 1, 2011

Did Erasmus Darwin foreshadow the tweaking of his grandson’s paradigm?

0 Comments

image: To Err is Human

To Err is Human

By | February 1, 2011

This is your brain on emotions.

0 Comments

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS